Skip to main content
logo
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2525
-0.0195 (-7.17%)
At close: Aug 28, 2026, 4:00 PM EDT
0.2575
+0.0050 (1.98%)
After-hours: Aug 28, 2026, 7:52 PM EDT

Mereo BioPharma Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-28.1-41.88-43.25-29.47-42.2217.23
Depreciation & Amortization
1.191.151.091.060.890.87
Loss (Gain) From Sale of Assets
------0.15
Stock-Based Compensation
6.187.67.394.924.774.47
Other Operating Activities
-3.935.362.313.94-9.91-27.01
Change in Accounts Receivable
------0.8
Change in Accounts Payable
0.03-1.380.15-1.260.62-1.7
Change in Other Net Operating Assets
-0.71-1.83-0.52-0.33-2.97-
Operating Cash Flow
-25.35-30.97-32.83-21.13-48.82-7.09
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.02---0.01-0.72
Sale (Purchase) of Intangibles
---0.7-0.4220.15
Other Investing Activities
-----0
Investing Cash Flow
--0.02-0.7-0.421.99-0.57

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
----3.19--0.94
Net Debt Issued (Repaid)
----3.19--0.94
Issuance of Common Stock
0.040.534711.61-106.4
Other Financing Activities
--0.2-0.85-0.440.2-0.32
Financing Cash Flow
0.040.3346.157.970.2105.15

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.71.85-0.232.82-12.58-1.58
Miscellaneous Cash Flow Adjustments
----0--
Net Cash Flow
-26.01-28.8112.38-10.76-59.2295.9

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-25.35-30.99-32.83-21.13-48.83-7.82
Free Cash Flow Growth
------
Free Cash Flow Margin
--6198.20%--211.32%--15.83%
Free Cash Flow Per Share
-0.16-0.19-0.22-0.16-0.41-0.07
Levered Free Cash Flow
-13.66-17.92-21.5-14.17-32.74-9.08
Unlevered Free Cash Flow
-13.6-17.76-20.64-12.37-30.13-5.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.030.030.020.880.02-
Cash Income Tax Paid
----1.341.88-
Change in Working Capital
-0.68-3.2-0.37-1.59-2.35-2.5
SEC Filings: 10-K · 10-Q